Skip to main content
. 2016 Feb 26;8(2):211–219. doi: 10.4330/wjc.v8.i2.211

Table 1.

Interventional and randomized ongoing clinical trials on the use of hydralazine and procainamide in cardiovascular diseases

No. Status Condition No. of enrolled patients Intervention
NCT00684489 Completed Hypertension 52 Hydralazine and other drugs
NCT02305095 Not open for participant recruitment Heart failure 500 (estimated enrollment) Hydralazine in combination with isosorbide dinitrate
NCT00661895 Completed Hypertension 99 Hydralazine and other drugs
NCT00599235 Completed Hypertension 30 Hydralazine, sildenafil, and placebo
NCT00223717 Recruiting participants Hypertension 160 (estimated enrollment) Hydralazine and other drugs
NCT01255475 Completed Heart failure, cardiac failure, and congestive heart failure 21 Hydralazine/amlodipine and placebo
NCT01516346 Recruiting participants Heart failure and congestive heart failure 54 (estimated enrollment) Hydralazine, isosorbide dinitrate, and placebo
NCT01822808 Recruiting participants Acute heart failure and left ventricular dysfunction 500 (estimated enrollment) Hydralazine, isosorbide dinitrate, and placebo
NCT00000499 Completed Cardiovascular diseases, heart diseases, hypertension, and vascular diseases Not provided Hydralazine, reserpine, chlorthalidone, and metoprolol
NCT02050529 Recruiting participants Hypertension, Pregnancy induced 180 (estimated enrollment) Hydralazine, labetalol
NCT01538875 Completed Hypertension, Pregnancy induced 261 Hydralazine, labetalol
NCT00383799 Unknown Ventricular tachycardia 302 (estimated enrollment) Procainamide, amiodarone
NCT00000464 Completed Arrhythmia, Cardiovascular diseases 115 Procainamide, quinidine, disopyramide, and other drugs
NCT00702117 Completed Atrial fibrillation, tachycardia 123 Procainamide, ajmaline, flecainide
NCT00589303 Terminated Atrial fibrillation, heart failure 27 Rhythm control drugs: Procainamide and other drugs
NCT00000556 Completed Arrhythmia, atrial fibrillation, cardiovascular diseases 4060 Procainamide and other drugs
NCT01205529 Recruiting Atrial fibrillation 750 (estimated enrollment) Procainamide